Co-Authors
This is a "connection" page, showing publications co-authored by CEZAR ILIESCU and KAVEH KARIMZAD.
Connection Strength
1.992
-
Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. 2022; 9:1019284.
Score: 0.226
-
The Year in Cardio-oncology 2022. Curr Probl Cardiol. 2023 Jan; 48(1):101435.
Score: 0.224
-
Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas). 2022 Jul 01; 58(7).
Score: 0.221
-
Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin. 2019 Nov; 37(4):469-486.
Score: 0.183
-
Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol. 2019 08; 19(4):382-387.
Score: 0.180
-
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
Score: 0.174
-
Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med. 2018; 5:48.
Score: 0.166
-
Progressive and Reversible Conduction Disease With Checkpoint Inhibitors. Can J Cardiol. 2017 10; 33(10):1335.e13-1335.e15.
Score: 0.155
-
Ischemic Heart Disease: Special Considerations in Cardio-Oncology. Curr Treat Options Cardiovasc Med. 2017 May; 19(5):37.
Score: 0.154
-
Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients? J Am Coll Cardiol. 2016 09 06; 68(10):1143-4.
Score: 0.147
-
Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer. JACC CardioOncol. 2022 Sep; 4(3):341-350.
Score: 0.056
-
Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):275-290.
Score: 0.054
-
QT Prolongation in Cancer Patients. Front Cardiovasc Med. 2021; 8:613625.
Score: 0.050